Back
BridgeBio Pharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
BBIO
BridgeBio Pharma, Inc.
Last Price:
$68.14
Seasonality Move:
-7.53%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BridgeBio Pharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.22 | Sell |
| 20-day SMA: | 74.44 | Sell |
| 50-day SMA: | 75.26 | Sell |
| 200-day SMA: | 56.54 | Buy |
| 8-day EMA: | 72.29 | Sell |
| 20-day EMA: | 73.74 | Sell |
| 50-day EMA: | 73.26 | Sell |
| 200-day EMA: | 59.53 | Buy |
BridgeBio Pharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.08 | Sell |
| Relative Strength Index (14 RSI): | 38.77 | Sell |
| Chaikin Money Flow: | -2945013 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.19 - 78.93) | Sell |
| Bollinger Bands (100): | (60.11 - 77.21) | Sell |
BridgeBio Pharma, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BridgeBio Pharma, Inc. Stock
Is BridgeBio Pharma, Inc. Stock a Buy?
-
BridgeBio Pharma, Inc. share price is 68.14 while BBIO 8-day simple moving average is 73.22, which is a Sell signal.
-
The stock price of BBIO is 68.14 while BridgeBio Pharma, Inc. 20-day SMA is 74.44, which makes it a Sell.
-
BridgeBio Pharma, Inc. 50-day simple moving average is 75.26 while BBIO share price is 68.14, making it a Sell technically.
-
BBIO stock price is 68.14 and BridgeBio Pharma, Inc. 200-day simple moving average is 56.54, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
35
BridgeBio Pharma, Inc. (BBIO)
is a Sell
Is BridgeBio Pharma, Inc. a Buy or a Sell?
-
BridgeBio Pharma, Inc. stock is rated a SellThe current BridgeBio Pharma, Inc. [BBIO] share price is $68.14. The Score for BBIO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma, Inc. Stock Info
Market Cap:
13.1B
Price in USD:
68.14
Share Volume:
5.1M
BridgeBio Pharma, Inc. 52-Week Range
52-Week High:
84.94
52-Week Low:
28.33
Sell
35
BridgeBio Pharma, Inc. (BBIO)
is a Sell
BridgeBio Pharma, Inc. Share Price Forecast
-
What is the BridgeBio Pharma, Inc. stock price today?The BridgeBio Pharma, Inc. stock price is 68.14 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma, Inc. is overvalued.
Is BridgeBio Pharma, Inc. Stock a Buy?
-
BridgeBio Pharma, Inc. share price is 68.14 while BBIO 8-day exponential moving average is 72.29, which is a Sell signal.
-
The stock price of BBIO is 68.14 while BridgeBio Pharma, Inc. 20-day EMA is 73.74, which makes it a Sell.
-
BridgeBio Pharma, Inc. 50-day exponential moving average is 73.26 while BBIO share price is 68.14, making it a Sell technically.
-
BBIO stock price is 68.14 and BridgeBio Pharma, Inc. 200-day simple moving average is 59.53, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma, Inc.
Is BridgeBio Pharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.56 per share, and an increase next year of $2.61 per share.
Technical Analysis of BridgeBio Pharma, Inc.
Should I short BridgeBio Pharma, Inc. stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is -1.08, suggesting BridgeBio Pharma, Inc. is a Sell
-
BridgeBio Pharma, Inc. Relative Strength Index (RSI) is 38.77, which suggest BridgeBio Pharma, Inc. is oversold
-
The Bollinger Bands (25) for BridgeBio Pharma, Inc. is (71.19 - 78.93), which suggest BridgeBio Pharma, Inc. is a Sell
-
The Bollinger Bands (100) for BridgeBio Pharma, Inc. is (60.11 - 77.21), which suggest BridgeBio Pharma, Inc. is a Sell
* BridgeBio Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.